SABBY 13G HEB 4.24.18

Company

AIM ImmunoTech Inc.

Filed

April 24, 2018

Accession Number

0001535610-18-000081

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →